Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Crossref DOI link: https://doi.org/10.1007/s40264-019-00816-3
Published Online: 2019-04-22
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghosh, Subrata
Gensler, Lianne S.
Yang, Zijiang
Gasink, Chris
Chakravarty, Soumya D.
Farahi, Kamyar
Ramachandran, Paraneedharan
Ott, Elyssa
Strober, Bruce E.
Text and Data Mining valid from 2019-04-22
Article History
First Online: 22 April 2019